Trial intelligence / Profile preview

Carbetocin vs Syntometrine for PPH Prevention in Obese Women

NCT03693599Phase 4Completed

Sponsor
Cairo University
Start
Oct 2018
Primary completion
Sep 2019
Modality
Peptides
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Cairo University. Primary endpoint: Incidence of Postpartum Hemorrhage at 24 hours. Started Oct 2018; status: completed.

02

Drugs

carbetocin
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT03693599.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03693599.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call